The vitamin K cycle

被引:137
作者
Oldenburg, Johannes [1 ]
Marinova, Mitka [1 ]
Moier-Reible, Clemens [2 ]
Watzka, Matthias [1 ]
机构
[1] Univ Clin Bonn, Inst Expt Hematol & Transfus Med, D-53105 Bonn, Germany
[2] Univ Wurzburg, Inst Human Genet, D-97074 Wurzburg, Germany
来源
VITAMIN K | 2008年 / 78卷
关键词
D O I
10.1016/S0083-6729(07)00003-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vitamin K is a collective term for lipid-like naphthoquinone derivatives synthesized only in eubacteria and plants and functioning as electron carriers in energy transduction pathways and as free radical scavengers maintaining intracellular redox homeostasis. Paradoxically, vitamin K is a required micronutrient in animals for protein posttranslational modification of some glutamate side chains to gamma-carboxyglutamate. The majority of gamma-carboxylated proteins function in blood coagulation. Vitamin K shuttles reducing equivalents as electrons between two enzymes: VKORC1, which is itself reduced by an unknown ER lumenal reductant in order to reduce vitamin K epoxide (K>O) to the quinone form (KH2); and gamma-glutamyl carboxylase, which catalyzes posttranslational gamma-carboxylation and oxidizes KH2 to K>O. This article reviews vitamin K synthesis and the vitamin K cycle, outlines physiological roles of various vitamin K-dependent, gamma-carboxylated proteins, and summarizes the current understanding of clinical phenotypes caused by genetic mutations affecting both enzymes of the vitamin K cycle. (C) 2008 Elsevier Inc.
引用
收藏
页码:35 / 62
页数:28
相关论文
共 133 条
[71]   Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins [J].
Murshed, M ;
Schinke, T ;
McKee, MD ;
Karsenty, G .
JOURNAL OF CELL BIOLOGY, 2004, 165 (05) :625-630
[72]  
MUTUCUMARANA VP, 2003, J BIOL CHEM, V278
[73]  
MYSZKA DG, 1991, J BIOL CHEM, V266, P4789
[74]   Vitamin K intake and stability of oral anticoagulant treatment [J].
Oldenburg, J .
THROMBOSIS AND HAEMOSTASIS, 2005, 93 (05) :799-800
[75]  
Oldenburg J, 2000, THROMB HAEMOSTASIS, V84, P937
[76]   MENAQUINONE (VITAMIN-K2) BIOSYNTHESIS - EVIDENCE THAT THE ESCHERICHIA-COLI MEND GENE ENCODES BOTH 2-SUCCINYL-6-HYDROXY-2,4-CYCLOHEXADIENE-1-CARBOXYLIC ACID SYNTHASE AND ALPHA-KETOGLUTARATE DECARBOXYLASE ACTIVITIES [J].
PALANIAPPAN, C ;
SHARMA, V ;
HUDSPETH, MES ;
MEGANATHAN, R .
JOURNAL OF BACTERIOLOGY, 1992, 174 (24) :8111-8118
[77]  
Palareti G, 1997, THROMB HAEMOSTASIS, V78, P1438
[79]   The genetic basis of resistance to anticoagulants in rodents [J].
Pelz, HJ ;
Rost, S ;
Hünerberg, M ;
Fregin, A ;
Heiberg, AC ;
Baert, K ;
MacNicoll, AD ;
Prescott, CV ;
Walker, AS ;
Oldenburg, J ;
Müller, CR .
GENETICS, 2005, 170 (04) :1839-1847
[80]   IS THIOREDOXIN THE PHYSIOLOGICAL VITAMIN-K EPOXIDE REDUCING AGENT [J].
PREUSCH, PC .
FEBS LETTERS, 1992, 305 (03) :257-259